/Companies

Phyllome

11 employees on LinkedIn · 1 known investors

Find your way into Phyllome

Sign up to see every warm intro you have to Phyllome

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Phyllome team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.

Founders & leadership

SESebastien Eckersley-Maslin
Sebastien Eckersley-MaslinFounder and CEOSebastien Eckersley-Maslin is a founder and former CEO of BlueChilli, a venture technology firm, who previously worked as a weapons engineer with the Royal Australian Navy and has led multiple startup exits. He founded Phyllome, which develops edible plants engineered to produce therapeutic peptides.

Investors · 1

Frequently asked questions

What does Phyllome do?
Phyllome grows edible plants engineered to express cyclotide therapeutic peptides, turning them into functional foods with controlled therapeutic dosing as an oral alternative to injected or synthetic drugs. Its pipeline targets analgesic, cholesterol-modulating, and appetite-regulating applications, developed with the University of Queensland's Institute for Molecular Bioscience.
Who founded Phyllome?
Phyllome was founded by Sebastien Eckersley-Maslin.
Who are Phyllome's investors?
Phyllome's investors include Tenacious Ventures.